Fast, accurate and accessible testing is important in dealing with tracking and halting the spread of coronavirus COVID-19. We have reached a milestone in this aspect with the approval of Drug Controller General of India (DCGI) for the commercial launch of India's first Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) coronavirus test 'Feluda' (FNCAS9 Editor-Limited Uniform Detection Assay), developed by the Tata Group and CSIR-IGIB (Institute of Genomics and Integrative Biology). What is CRISPR? CRISPR (clustered regularly interspaced palindromic repeats) is a defense mechanism, present in bacteria, which confers immunity against phages (Viruses infecting bacteria). ...Read More
All Blogs
All Blogs in the site. My husband says this is a nessary selector to select alll blogs irrespective of the category











